Serum xanthurenic acid levels: Reduced in subjects at ultra high risk for psychosis

被引:8
|
作者
Curto, Martina [1 ,2 ,3 ]
Lionetto, Luana [4 ]
Fazio, Francesco [5 ]
Corigliano, Valentina [1 ]
Comparelli, Anna [6 ]
Ferracuti, Stefano [1 ]
Simmaco, Maurizio [4 ,6 ]
Nicoletti, Ferdinando [5 ,7 ]
Baldessarini, Ross J. [3 ,8 ]
机构
[1] Sapienza Univ Rome, Dept Human Neurosci, Viale Univ 30, I-00185 Rome, Italy
[2] ASL Roma 5, Dept Mental Hlth, Via Esplos 9, I-00034 Colleferro, RM, Italy
[3] McLean Hosp, Int Mood & Psychot Disorders Res Consortium, 115 Mill St, Belmont, MA 02178 USA
[4] St Andrea Hosp, Adv Mol Diagnost Unit, Rome, Italy
[5] IRCCS Neuromed, Pozzilli, IS, Italy
[6] Sapienza Univ Rome, St Andrea Hosp, Dept Neurosci Mental Hlth & Sensory Organs NESMOS, Rome, Italy
[7] Sapienza Univ, Dept Physiol & Pharmacol, Rome, Italy
[8] Harvard Med Sch, Dept Psychiat, Boston, MA 02115 USA
关键词
Kynurenine; Schizophrenia; Xanthurenic acid; Ultra-high risk; Glutamate; METABOTROPIC GLUTAMATE RECEPTORS; SCHIZOPHRENIA;
D O I
10.1016/j.schres.2019.02.020
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
引用
收藏
页码:465 / 466
页数:2
相关论文
共 50 条
  • [31] Striatal D2 receptor binding in subjects at ultra high risk for psychosis
    Bloemen, O.
    Koning, M. D.
    Booij, J.
    Linszen, D.
    Amelsvoort, T. V.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2010, 13 : 214 - 214
  • [32] Environmental factors and social adjustment as predictors of a first psychosis in subjects at ultra high risk
    Dragt, Sara
    Nieman, Dorien H.
    Veltman, Doede
    Becker, Hiske E.
    van de Fliert, Reinaud
    de Haan, Lieuwe
    Linszen, Don H.
    SCHIZOPHRENIA RESEARCH, 2011, 125 (01) : 69 - 76
  • [33] Neuropsychology of subjects with ultra-high risk (UHR) of psychosis: A critical analysis of the literature
    Mam-lam-Fook, C.
    Danset-Alexandre, C.
    Pedron, L.
    Amado, I.
    Gaillard, R.
    Krebs, M-O.
    ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE, 2017, 43 (03): : 241 - 253
  • [34] P300 AMPLITUDE REDUCTION IN SUBJECTS AT ULTRA HIGH-RISK FOR PSYCHOSIS
    Keskin-Ergen, H. Yasemin
    Ucok, Alp
    Gode, Evrim
    Devrim-Ucok, Muege
    SCHIZOPHRENIA RESEARCH, 2010, 117 (2-3) : 361 - 362
  • [35] Hippocampal and anterior cingulate morphology in subjects at ultra high-risk for psychosis:: The role of family history of psychosis
    Yücel, M
    Wood, SJ
    Velakoulis, D
    Phillips, LJ
    Yung, AR
    McGorry, PD
    Pantelis, C
    SCHIZOPHRENIA RESEARCH, 2004, 67 (01) : 50 - 50
  • [36] Hippocampal Glutamate Levels and Striatal Dopamine D2/3 Receptor Occupancy in Subjects at Ultra High Risk of Psychosis
    Bloemen, Oswald J. N.
    Gleich, Tobias
    de Koning, Mariken B.
    Alvis, Fabiana da Silva
    de Haan, Lieuwe
    Linszen, Don H.
    Booij, Jan
    van Amelsvoort, Therese A. M. J.
    BIOLOGICAL PSYCHIATRY, 2011, 70 (01) : E1 - E2
  • [37] Are we really mapping psychosis risk? Neuroanatomical signature of affective disorders in subjects at ultra high risk
    Modinos, G.
    Allen, P.
    Frascarelli, M.
    Tognin, S.
    Valmaggia, L.
    Xenaki, L.
    Keedwell, P.
    Broome, M.
    Valli, I.
    Woolley, J.
    Stone, J. M.
    Mechelli, A.
    Phillips, M. L.
    McGuire, P.
    Fusar-Poli, P.
    PSYCHOLOGICAL MEDICINE, 2014, 44 (16) : 3491 - 3501
  • [38] Reduced volume in the anterior internal capsule but its maintained correlation with the frontal gray matter in subjects at ultra-high risk for psychosis
    Han, Hyun Jung
    Jung, Wi Hoon
    Jang, Joon Hwan
    Hwang, Jae Yeon
    Kim, Sung Nyun
    Byun, Min Soo
    Lee, Yoon Joo
    Choi, Chi-Hoon
    Kwon, Jun Soo
    PSYCHIATRY RESEARCH-NEUROIMAGING, 2012, 204 (2-3) : 82 - 90
  • [39] Reduced Dopamine Response to Amphetamine in Subjects at Ultra-High Risk for Addiction
    Casey, Kevin F.
    Benkelfat, Chawki
    Cherkasova, Mariya V.
    Baker, Glen B.
    Dagher, Alain
    Leyton, Marco
    BIOLOGICAL PSYCHIATRY, 2014, 76 (01) : 23 - 30
  • [40] The Ultra High Risk Approach to Define Psychosis Risk
    Yung, Alison R.
    Fusar-Poli, Paolo
    Nelson, Barnaby
    CURRENT PHARMACEUTICAL DESIGN, 2012, 18 (04) : 346 - 350